Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma

Despite the overall success of using R-CHOP for the care for non-Hodgkin’s lymphoma patients, it is clear that the disease is quite complex and new insight is needed to further stratify the patient for a better personized treatment. In current study, based on previous studies from animal model, new...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhenhua Xian, Dehua Fu, Shuang Liu, Yang Yao, Chun Gao
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2019/7627384
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552618439737344
author Zhenhua Xian
Dehua Fu
Shuang Liu
Yang Yao
Chun Gao
author_facet Zhenhua Xian
Dehua Fu
Shuang Liu
Yang Yao
Chun Gao
author_sort Zhenhua Xian
collection DOAJ
description Despite the overall success of using R-CHOP for the care for non-Hodgkin’s lymphoma patients, it is clear that the disease is quite complex and new insight is needed to further stratify the patient for a better personized treatment. In current study, based on previous studies from animal model, new panels combining well-established cytokine (BAFF) and autoantibodies (anti-SSA/Ro) with newly identified cytokine (IL14) and autoantibodies (TSA) were used to evaluate the association between B cell growth factor and Sjögren’s related autoantibodies in NHL patients. The result clearly indicates that there was a unique difference between BAFF and IL14 in association with autoantibodies. While serum BAFF was negatively associated with the presence of both traditional anti-SSA/Ro and novel TSA antibodies in GI lymphoma patient, IL14 was positively associated with the presence of both traditional anti-SSA/Ro and novel TSA antibodies in non-GI lymphoma patient. Long-term follow-ups on these patients and evaluation of their response to the R-CHOP treatment and recurrence rate will be very interesting. Our result provides a solid evidence to support using novel diagnostic panel to better stratify the NHL patients.
format Article
id doaj-art-140153f2e8d34906beca512838d3d9a5
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-140153f2e8d34906beca512838d3d9a52025-02-03T05:58:16ZengWileyJournal of Immunology Research2314-88612314-71562019-01-01201910.1155/2019/76273847627384Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s LymphomaZhenhua Xian0Dehua Fu1Shuang Liu2Yang Yao3Chun Gao4Department of Gastrointestinal Surgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Gastrointestinal Surgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Gastrointestinal Surgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Gastrointestinal Surgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Gastrointestinal Surgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, ChinaDespite the overall success of using R-CHOP for the care for non-Hodgkin’s lymphoma patients, it is clear that the disease is quite complex and new insight is needed to further stratify the patient for a better personized treatment. In current study, based on previous studies from animal model, new panels combining well-established cytokine (BAFF) and autoantibodies (anti-SSA/Ro) with newly identified cytokine (IL14) and autoantibodies (TSA) were used to evaluate the association between B cell growth factor and Sjögren’s related autoantibodies in NHL patients. The result clearly indicates that there was a unique difference between BAFF and IL14 in association with autoantibodies. While serum BAFF was negatively associated with the presence of both traditional anti-SSA/Ro and novel TSA antibodies in GI lymphoma patient, IL14 was positively associated with the presence of both traditional anti-SSA/Ro and novel TSA antibodies in non-GI lymphoma patient. Long-term follow-ups on these patients and evaluation of their response to the R-CHOP treatment and recurrence rate will be very interesting. Our result provides a solid evidence to support using novel diagnostic panel to better stratify the NHL patients.http://dx.doi.org/10.1155/2019/7627384
spellingShingle Zhenhua Xian
Dehua Fu
Shuang Liu
Yang Yao
Chun Gao
Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma
Journal of Immunology Research
title Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma
title_full Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma
title_fullStr Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma
title_full_unstemmed Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma
title_short Association between B Cell Growth Factors and Primary Sjögren’s Syndrome-Related Autoantibodies in Patients with Non-Hodgkin’s Lymphoma
title_sort association between b cell growth factors and primary sjogren s syndrome related autoantibodies in patients with non hodgkin s lymphoma
url http://dx.doi.org/10.1155/2019/7627384
work_keys_str_mv AT zhenhuaxian associationbetweenbcellgrowthfactorsandprimarysjogrenssyndromerelatedautoantibodiesinpatientswithnonhodgkinslymphoma
AT dehuafu associationbetweenbcellgrowthfactorsandprimarysjogrenssyndromerelatedautoantibodiesinpatientswithnonhodgkinslymphoma
AT shuangliu associationbetweenbcellgrowthfactorsandprimarysjogrenssyndromerelatedautoantibodiesinpatientswithnonhodgkinslymphoma
AT yangyao associationbetweenbcellgrowthfactorsandprimarysjogrenssyndromerelatedautoantibodiesinpatientswithnonhodgkinslymphoma
AT chungao associationbetweenbcellgrowthfactorsandprimarysjogrenssyndromerelatedautoantibodiesinpatientswithnonhodgkinslymphoma